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Drug is special goods to prevent diseases or used for reha-
bilitation and health care, and therefore is essential for
human society development. Drug safety directly related
to people’s health and life safety, and also tightly associated
with the government management and public safety. Our
national pharmaceutical and health care policy has paid
equal attentions on Traditional Chinese Medicine and
western chemical drugs, and implemented the significant
new drugs creation strategy. Plenty of strategies,
approaches and technologies have been applied in the
drug research field, and have promoted the fast develop-
ment of biomedical industry. Now we are on the way to
be a big country of pharmacy, which supplies favorable
conditions and available development spaces of construct-
ing the novel drug regulatory system.
According to the overall serious problems of China bio-
medical industry, such as small scale, low concentration;
excess capacity, weak innovation and competition on mar-
ket, and homogenization under low-end technology and
quality, etc. Additionally, the development of society is
facing urbanization, industrialization and aging problems,
new requirements of the safety, efficient and availableness
of drug have been raised. Therefore, Constructing the new
system of national drug regulatory, improve the level of
drug quality control and ensure the drug safety in society
are essential products as the progress of times and society
development, and also are important questions that to pay
more attentions during drug regulatory process. We need
to deeply understand them with the basis of practice and
innovate drug concept and measures, to ensure the drug
safety and efficient is controllable. After all, we need to
persist on thinking systematically, enhance the top design,
emphasize on the entire process regulatory, to construct a
new system of drug regulatory which is suitable to domes-
tic conditions.
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